We urge interested persons and their families to act quickly, as this project will soon have a long waiting list," said Regan Development.

During the first reading of the request for rezoning on June 2, which featured numerous public testimony against the ...

An article published in the Times News on June 19, 2025, entitled “Panther OKs budget with slight increase,” quotes outgoing business manager Jesse Walck as saying, “the tax increase was ...

OS Therapies Submits Request for Regenerative Medicine ... Designation to U.S. FDA for OST-HER2 in the Prevention ... and their inclusion on this site does not imply any form of ...

Scilex’s commercial products include: (i) ZTlido ® (lidocaine topical system) 1.8%, a prescription lidocaine topical product approved by the U.S. Food and Drug Administration (the “FDA”) for the ...

PALO ALTO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and ...

Zeit Aktuelle Nachrichten; 01.05. Scilex Holding Company to Present Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of ...

Scilex Holding Company Announces FDA Has Approved Our Request for the Orphan Drug Designation for Colchicine for the Treatment of Pericarditis Scilex Holding Company - GlobeNewswire - Wed Apr 16 ...

Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.Pericarditis is an inflammation of the ...

Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.Pericarditis is an inflammation of the ...